INSMED INC Debt Securities, Available-for-sale, Noncurrent
INSMED INC (INSM) had Debt Securities, Available-for-sale, Noncurrent of $9.80 million as of 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2022-08-04
- 2022-06-30: Debt Securities, Available-for-sale, Noncurrent $9.80M.
- 2022-03-31: Debt Securities, Available-for-sale, Noncurrent $29.60M.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2022-06-30 | $9.80M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $29.60M 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |